- Home
- HCWB vs GAME Comparison
HCWB vs GAME Comparison
Compare HCWB & GAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- GAME
- Stock Information
- Founded
- HCWB 2018
- GAME 2011
- Country
- HCWB United States
- GAME United States
- Employees
- HCWB N/A
- GAME N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- GAME
- Sector
- HCWB Health Care
- GAME
- Exchange
- HCWB Nasdaq
- GAME Nasdaq
- Market Cap
- HCWB 17.2M
- GAME 25.8M
- IPO Year
- HCWB 2021
- GAME 2009
- Fundamental
- Price
- HCWB $0.35
- GAME $0.67
- Analyst Decision
- HCWB
- GAME Strong Buy
- Analyst Count
- HCWB 0
- GAME 3
- Target Price
- HCWB N/A
- GAME $3.67
- AVG Volume (30 Days)
- HCWB 281.9K
- GAME 295.4K
- Earning Date
- HCWB 03-31-2025
- GAME 04-15-2025
- Dividend Yield
- HCWB N/A
- GAME N/A
- EPS Growth
- HCWB N/A
- GAME N/A
- EPS
- HCWB N/A
- GAME N/A
- Revenue
- HCWB $3,495,990.00
- GAME $99,072,646.00
- Revenue This Year
- HCWB $229.19
- GAME $102.01
- Revenue Next Year
- HCWB N/A
- GAME $17.88
- P/E Ratio
- HCWB N/A
- GAME N/A
- Revenue Growth
- HCWB 22.27
- GAME 210.51
- 52 Week Low
- HCWB $0.21
- GAME $0.60
- 52 Week High
- HCWB $2.52
- GAME $2.25
- Technical
- Relative Strength Index (RSI)
- HCWB 46.07
- GAME 30.46
- Support Level
- HCWB $0.33
- GAME $0.60
- Resistance Level
- HCWB $0.38
- GAME $0.91
- Average True Range (ATR)
- HCWB 0.03
- GAME 0.09
- MACD
- HCWB -0.00
- GAME -0.03
- Stochastic Oscillator
- HCWB 33.18
- GAME 7.19
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is engaged to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Its next generation media, entertainment, and technology help creators and maximize its brand partners return on investment. Its purpose-built platform, provide marketing and creative services, offer data and analytics solutions, and amplify awareness through FaZe Clan.